Curcuminoids and Boswellia serrata extracts combination decreases tendinopathy symptoms: findings from an open-label post-observational study

References

• Riel H, Lindstrøm CF, Rathleff MS, et al. Prevalence and incidence rate of lower-extremity tendinopathies in a Danish general practice: a registry-based study. BMC Musculoskelet Disord. 2019;20(1):239.
   PubMed Web of Science ®Google Scholar
• Khan KM, Cook JL, Kannus P, et al. Time to abandon the “tendinitis” myth. BMJ. 2002;324(7338):626–627.
   PubMed Web of Science ®Google Scholar
• Knapik JJ, Pope R. Achilles tendinopathy: pathophysiology, epidemiology, diagnosis, treatment, prevention, and screening. J Spec Oper Med. 2020;20(1):125–140.
   PubMedGoogle Scholar
• Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009;43(6):409–416.
   PubMed Web of Science ®Google Scholar
• Tran PHT, Malmgaard-Clausen NM, Puggaard RS, et al. Early development of tendinopathy in humans: sequence of pathological changes in structure and tissue turnover signaling. FASEB J. 2020;34(1):776–788.
   PubMed Web of Science ®Google Scholar
• Longo UG, Ronga M, Maffulli N. Achilles tendinopathy. Sports Med Arthrosc Rev. 2018;26(1):16–30.
   PubMed Web of Science ®Google Scholar
• Steinmann S, Pfeifer CG, Brochhausen C, et al. Spectrum of tendon pathologies: triggers, trails and end-state. IJMS. 2020;21(3):844.
   Web of Science ®Google Scholar
• Hess GW. Achilles tendon rupture: a review of etiology, population, anatomy, risk factors, and injury prevention. Foot Ankle Spec. 2010;3(1):29–32.
   PubMedGoogle Scholar
• Knobloch K. Drug-induced tendon disorders. In: Ackermann P, Hart D, editors. Metabolic influences on risk for tendon disorders. Advances in experimental medicine and biology, Vol. 920. Cham: Springer; 2016.
   Google Scholar
• Stephenson AL, Wu W, Cortes D, et al. Tendon injury and fluoroquinolone use: a systematic review. Drug Saf. 2013;36(9):709–721.
   PubMed Web of Science ®Google Scholar
• Vander Doelen T, Jelley W. Non-surgical treatment of patellar tendinopathy: a systematic review of randomized controlled trials. J Sci Med Sport. 2020;23(2):118–124.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang JH. PRP treatment efficacy for tendinopathy: a review of basic science studies. Biomed Res Int. 2016;2016:9103792.
   PubMed Web of Science ®Google Scholar
• Costa Almeida R, Babo PS, Reis RL, et al. Platelet-rich blood derivatives for tendon regeneration. J Am Acad Orthop Surg. 2020;28(5):e202–e205.
   PubMed Web of Science ®Google Scholar
• Chen JM, Willers C, Xu J, et al. Autologous tenocyte therapy using porcine-derived bioscaffolds for massive rotator cuff defect in rabbits. Tissue Eng. 2007;13(7):1479–1491.
   PubMedGoogle Scholar
• Fusini F, Bisicchia S, Bottegoni C, et al. Nutraceutical supplement in the management of tendinopathies: a systematic review. Muscles Ligaments Tendons J. 2016;6(1):48–57.
   PubMedGoogle Scholar
• Siemoneit U, Pergola C, Jazzar B, et al. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance. Eur J Pharmacol. 2009;606(1–3):246–254.
   PubMed Web of Science ®Google Scholar
• Buhrmann C, Mobasheri A, Busch F, et al. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2011;286(32):28556–28566.
   PubMed Web of Science ®Google Scholar
• Shakibaei M, John T, Schulze-Tanzil G, et al. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007;73(9):1434–1445.
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Clutterbuck AL, Allaway D, et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage. 2010;18(2):141–149.
   PubMed Web of Science ®Google Scholar
• Ammon HP. Boswellic acids and their role in chronic inflammatory diseases. Adv Exp Med Biol. 2016;928:291–327.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Osani MC, Al-Eid F, et al. Efficacy of curcumin and Boswellia for knee osteoarthritis: systematic review and meta-analysis. Semin Arthritis Rheum. 2018;.
   Web of Science ®Google Scholar
• Liu X, Machado GC, Eyles JP, et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167–175.
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Malaise M, Wittoek R, et al. Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study. Arthritis Res Ther. 2019;21(1):179.
   PubMed Web of Science ®Google Scholar
• Kimmatkar N, Thawani V, Hingorani L, et al. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3–7.
   PubMed Web of Science ®Google Scholar
• Mathy-Hartert M, Jacquemond-Collet I, Priem F, et al. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res. 2009;58:899.
   PubMed Web of Science ®Google Scholar
• Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011;50(6):349–369.
   PubMed Web of Science ®Google Scholar
• Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–779.
   PubMed Web of Science ®Google Scholar
• Jomaa G, Kwan CK, Fu SC, et al. A systematic review of inflammatory cells and markers in human tendinopathy. BMC Musculoskelet Disord. 2020;21(1):78.
   PubMed Web of Science ®Google Scholar